19.7.2010, Press Release
Therapeutic HIV-vaccine Phase II results
FIT Biotech Ltd Dr. Kalevi Reijonen, CEO & President Tel: + 358 408 435 695 kalevi.reijonen[at]fitbiotech.com
Back to News and Events